These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8477202)
1. Megakaryocytic ploidy in myelodysplastic syndromes. Kobayashi Y; Ozawa M; Maruo N; Kondo M Leuk Lymphoma; 1993 Jan; 9(1-2):55-61. PubMed ID: 8477202 [TBL] [Abstract][Full Text] [Related]
2. Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients. Kobayashi Y; Uoshima N; Kimura S; Tanaka K; Wada K; Ozawa M; Maruo N; Kondo M Int J Hematol; 1995 Apr; 61(3):117-22. PubMed ID: 7599323 [TBL] [Abstract][Full Text] [Related]
3. Shift in the megakaryocyte ploidy in MDS patients: microcytofluorometry with DAPI staining after destaining of Wright-Giemsa stain. Kobayashi Y; Kimura S; Tanaka K; Wada K; Ozawa M; Horiuchi H; Maruo N; Kondo M Br J Haematol; 1991 Dec; 79(4):556-61. PubMed ID: 1772776 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the DNA content of megakaryocytes identified immunologically with that identified morphologically. Kobayashi Y; Takahashi Y; Chikayama S; Ikeda M; Uoshima N; Kimura S; Tanaka K; Wada K; Ozawa M; Sugano T; Maruo N; Kondo M Histochem Cell Biol; 1997 Aug; 108(2):115-20. PubMed ID: 9272430 [TBL] [Abstract][Full Text] [Related]
5. [Megakaryocyte ploidy in patients with myelodysplastic syndrome--by microcytofluorometry with DAPI staining after removal of Wright-Giemsa staining]. Kobayashi Y; Ozawa M; Maruo N; Kondo M Rinsho Ketsueki; 1989 Nov; 30(11):1915-22. PubMed ID: 2481752 [TBL] [Abstract][Full Text] [Related]
6. [Microcytofluorometrical measurement of DNA content in immunologically identified micromegakaryocytes of human bone marrow]. Kobayashi Y; Ozawa M; Maruo N; Kondo M Nihon Ketsueki Gakkai Zasshi; 1989 Nov; 52(7):1165-9. PubMed ID: 2482647 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of immunocytochemical staining versus Giemsa stain for detecting dysmegakaryopoiesis in myelodysplastic syndromes (MDS). Kawaguchi M; Nehashi Y; Aizawa S; Toyama K Eur J Haematol; 1990 Feb; 44(2):89-94. PubMed ID: 2318299 [TBL] [Abstract][Full Text] [Related]
8. [The relationship between ploidy and morphological classification of human megakaryocytes]. Kobayashi Y; Maruo N; Tanaka K; Kimura S; Wada K; Ozawa M; Horiuchi H; Kondo M Rinsho Byori; 1992 Jan; 40(1):81-6. PubMed ID: 1545529 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry. Das R; Hayer J; Dey P; Garewal G Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636 [TBL] [Abstract][Full Text] [Related]
10. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes. Thiele J; Titius BR; Kopsidis C; Fischer R Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):275-82. PubMed ID: 1279889 [TBL] [Abstract][Full Text] [Related]
11. Megakaryocytes increase in size within ploidy groups in response to the stimulus of thrombocytopenia. Ebbe S; Yee T; Carpenter D; Phalen E Exp Hematol; 1988 Jan; 16(1):55-61. PubMed ID: 3335233 [TBL] [Abstract][Full Text] [Related]
12. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens. Thiele J; Quitmann H; Wagner S; Fischer R J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Tomer A; Friese P; Conklin R; Bales W; Archer L; Harker LA; Burstein SA Blood; 1989 Aug; 74(2):594-601. PubMed ID: 2752135 [TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes. Thiele J; Hoffmann I; Bertsch HP; Fischer R Virchows Arch A Pathol Anat Histopathol; 1993; 423(1):33-8. PubMed ID: 8105604 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone marrow megakaryocyte ploidy distributions in persons with normal and abnormal platelet counts. Mazur EM; Lindquist DL; de Alarcon PA; Cohen JL J Lab Clin Med; 1988 Feb; 111(2):194-202. PubMed ID: 3276801 [TBL] [Abstract][Full Text] [Related]
16. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes. Li X; Pu Q Leuk Lymphoma; 2005 Mar; 46(3):387-91. PubMed ID: 15621828 [TBL] [Abstract][Full Text] [Related]
17. [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation]. Tomonaga M; Jinnai I; Kuriyama K; Nonaka H; Amenomori T; Matsuo T; Yoshida Y; Sasagawa I; Sadamori N; Ichimaru M Rinsho Ketsueki; 1989 Oct; 30(10):1788-99. PubMed ID: 2593245 [TBL] [Abstract][Full Text] [Related]
18. Application of megakaryocytic morphology in diagnosing 5q- syndrome. Thiede T; Engquist L; Billström R Eur J Haematol; 1988 Nov; 41(5):434-7. PubMed ID: 3208866 [TBL] [Abstract][Full Text] [Related]
19. [An immunohistochemical study on megakaryocytes in patients with myelodysplastic syndromes]. Liu SQ; Liu XF; Song SJ Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):288-90. PubMed ID: 7874762 [TBL] [Abstract][Full Text] [Related]
20. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome? Wong KF; Chan JK Br J Haematol; 1991 Apr; 77(4):509-14. PubMed ID: 2025576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]